- Home
- NINE vs CRIS Comparison
NINE vs CRIS Comparison
Compare NINE & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- CRIS
- Stock Information
- Founded
- NINE 2011
- CRIS 2000
- Country
- NINE United States
- CRIS United States
- Employees
- NINE N/A
- CRIS N/A
- Industry
- NINE Oilfield Services/Equipment
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NINE Energy
- CRIS Health Care
- Exchange
- NINE Nasdaq
- CRIS Nasdaq
- Market Cap
- NINE 23.8M
- CRIS 21.3M
- IPO Year
- NINE 2018
- CRIS 2000
- Fundamental
- Price
- NINE $0.88
- CRIS $1.81
- Analyst Decision
- NINE
- CRIS Strong Buy
- Analyst Count
- NINE 0
- CRIS 2
- Target Price
- NINE N/A
- CRIS $16.50
- AVG Volume (30 Days)
- NINE 8.9M
- CRIS 177.3K
- Earning Date
- NINE 08-05-2025
- CRIS 07-31-2025
- Dividend Yield
- NINE N/A
- CRIS N/A
- EPS Growth
- NINE N/A
- CRIS N/A
- EPS
- NINE N/A
- CRIS N/A
- Revenue
- NINE $562,450,000.00
- CRIS $11,202,000.00
- Revenue This Year
- NINE $3.64
- CRIS N/A
- Revenue Next Year
- NINE N/A
- CRIS $10.67
- P/E Ratio
- NINE N/A
- CRIS N/A
- Revenue Growth
- NINE N/A
- CRIS 14.17
- 52 Week Low
- NINE $0.44
- CRIS $1.02
- 52 Week High
- NINE $2.02
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- NINE 54.98
- CRIS 43.58
- Support Level
- NINE $0.85
- CRIS $1.50
- Resistance Level
- NINE $1.05
- CRIS $1.98
- Average True Range (ATR)
- NINE 0.14
- CRIS 0.19
- MACD
- NINE 0.00
- CRIS -0.05
- Stochastic Oscillator
- NINE 21.80
- CRIS 43.88
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.